All
Don't Claim Marijuana Products Cure Cancer, FDA Warns
November 2nd 2017Four companies drew the ire of the Food and Drug Administration this week for claiming that their marijuana-derived products can treat or cure cancer. The agency issued letters of warning, and threatened punitive action if the companies do not correct the violations.
Early Palliative Care Improves Coping Strategies and Quality of Life
November 1st 2017A study presented at the 2017 Palliative and Supportive Care in Oncology Symposium examined the effects of early-integrated palliative care on patients with advanced/incurable lung or non-colorectal gastrointestinal cancers.
FDA Approves Calquence for Mantle Cell Lymphoma
October 31st 2017Calquence (acalabrutinib) was granted an accelerated approval by the FDA to treat adult patients with mantle cell lymphoma (MCL) following at least one prior therapy. The approval was based on objective response rates (ORR) in a single-arm trial.
Approval Sought for Avastin in the Frontline Ovarian Cancer Setting
October 30th 2017If approved, the new indication would make frontline Avastin available in combination with carboplatin and paclitaxel, followed by Avastin alone, for women with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer. The FDA is expected to render a decision on the sBLA by June 25, 2018.